Optimization of ultracentrifugation‐based method to enhance the purity and proteomic profiling depth of plasma‐derived extracellular vesicles and particles

Author:

Wan Zurong12,Gu Jinghua12,Balaji Uthra12,Bojmar Linda34,Molina Henrik5,Heissel Søren5,Pagano Alexandra E.5,Peralta Christopher5,Shaashua Lee3,Ismailgeci Dorina6,Narozniak Hope K.6,Song Yi7,Jarnagin William R.7,Kelsen David P.6,Bromberg Jaqueline68,Pascual Virginia12,Zhang Haiying3ORCID

Affiliation:

1. Drukier Institute of Children's Health Weill Cornell Medicine New York New York USA

2. Department of Pediatrics Weill Cornell Medicine New York New York USA

3. Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Meyer Cancer Center Weill Cornell Medicine New York New York USA

4. Department of Clinical and Experimental Medicine Linköping University Linköping Sweden

5. Proteomics Resource Center The Rockefeller University New York New York USA

6. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA

7. Hepatopancreatobiliary Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA

8. Department of Medicine Weill Cornell Medicine New York New York USA

Abstract

AbstractCirculating extracellular vesicles and particles (EVPs) are being investigated as potential biomarkers for early cancer detection, prognosis, and disease monitoring. However, the suboptimal purity of EVPs isolated from peripheral blood plasma has posed a challenge of in‐depth analysis of the EVP proteome. Here, we compared the effectiveness of different methods for isolating EVPs from healthy donor plasma, including ultracentrifugation (UC)‐based protocols, phosphatidylserine‐Tim4 interaction‐based affinity capture (referred to as “PS”), and several commercial kits. Modified UC methods with an additional UC washing or size exclusion chromatography step substantially improved EVP purity and enabled the detection of additional proteins via proteomic mass spectrometry, including many plasma membrane and cytoplasmic proteins involved in vesicular regulation pathways. This improved performance was reproduced in cancer patient plasma specimens, resulting in the identification of a greater number of differentially expressed EVP proteins, thus expanding the range of potential biomarker candidates. However, PS and other commercial kits did not outperform UC‐based methods in improving plasma EVP purity. PS yielded abundant contaminating proteins and a biased enrichment for specific EVP subsets, thus unsuitable for proteomic profiling of plasma EVPs. Therefore, we have optimized UC‐based protocols for circulating EVP isolation, which enable further in‐depth proteomic analysis for biomarker discovery.

Funder

Hartwell Foundation

Feldstein Medical Foundation

National Cancer Institute

Breast Cancer Research Foundation

National Institute of Allergy and Infectious Diseases

Children's Cancer and Blood Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3